Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children.

Download
Citations
Altmetric
Author
Marks, M; Gwyn, S; Toloka, H; Kositz, C; Asugeni, J; Asugeni, R; Diau, J; Kaldor, JM; Romani, L; Redman-MacLaren, M; ...Date
2020-05-18Source Title
Clinical Infectious DiseasesPublisher
Oxford University Press (OUP)Affiliation
Paediatrics (RCH)Metadata
Show full item recordDocument Type
Journal ArticleCitations
Marks, M., Gwyn, S., Toloka, H., Kositz, C., Asugeni, J., Asugeni, R., Diau, J., Kaldor, J. M., Romani, L., Redman-MacLaren, M., MacLaren, D., Solomon, A. W., Mabey, D. C. W., Steer, A. C. & Martin, D. (2020). Impact of community treatment with ivermectin for the control of scabies on the prevalence of antibodies to Strongyloides stercoralis in children.. Clin Infect Dis, https://doi.org/10.1093/cid/ciaa584.Access Status
Open AccessAbstract
Prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (p = 0.019), demonstrating collateral benefits of ivermectin MDA in this setting.
Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References